|
Steven P. Richieri served as SVP/Head of Operations for Egea Biosciences from 2002 to 2005. Mr. Richieri was a key member of the executive team responsible for the sale of Egea to the Johnson and Johnson Corporation in May, 2004. From 1999 to 2002, Mr. Richieri was a co-founder and served as President and CEO of NuVista Technology Corporation, a privately held medical device company. During that time, he also a co-founded ALSP, a privately held drug discovery company. Prior to NuVista and ALSP, Mr. Richieri served as Chief Operating Officer for The Immune Response Corporation, a publicly-traded biotechnology company, where he was responsible for all corporate operations and product development activities between 1991 and 1999. From 1983 to 1991, Mr. Richieri was VP of Regulatory and Technical Affairs at Dura Pharmaceuticals. Mr. Richieri received a BS in Pharmacy from Rutgers College of Pharmacy and a MBA from the University of San Diego. | 